NPCE NEUROPACE INC

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30am PT (10:30am ET) on Thursday, January 10, 2024, in San Francisco, CA as well as host investor meetings prior to and during the conference.

The presentation will be accessible via live webcast . A webcast replay will be available for two weeks following the presentation in the Events section of NeuroPace’s Investor website at .

About NeuroPace, Inc.

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The RNS System is the only system that not only provides therapy, but monitors, detects, and records brain activity, helping patients reduce their seizure burden, while helping clinicians provide comprehensive patient care.

Investor Contact:

NeuroPace:

Jeremy Feffer

Managing Director

LifeSci Advisors



EN
19/12/2023

Underlying

NPCENEUROPACE INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NEUROPACE INC

 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 202...

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024 MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the first quarter of 2024 after market close on Wednesday, May 8, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a ...

April 17, 2024 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference MOUNTAIN VIEW, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will present at the Needham 23rd Annual Healthcare Conference, taking place virtually from April 8-11. Joel Becker, NeuroPace’s Chief Executive Officer, will provide a corporate presentation on Monday, April 8 at 3:45pm ET, and management will participate in one-on-one meetings with investors during the conference. The pr...

March 27, 2024 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million -- Revenue increased to $18.0 million in Q4 2023, a 41% increase over Q4 2022 -- -- Revenue increased to $65.4 million in 2023, a 44% increase over 2022 -- -- Provides full-year 2024 revenue guidance of between $73-$77 million -- -- Management scheduled to host a conference call today at 4:30 p.m. ET -- MOUNTAIN VIEW, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for t...

March 5, 2024 1 EN
 PRESS RELEASE
Free
NPCE NEUROPACE INC

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Result...

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024 MOUNTAIN VIEW, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter and full year 2023 after market close on Tuesday, March 5, 2024. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to th...

February 15, 2024 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
EUR 46.45
TRV Travelers Compa...
USB U.S. BANCORP ... (+39)

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

TRV TRAVELERS COMPANIES INC.
USB U.S. BANCORP
VNO VORNADO REALTY TRUST
VKTX VIKING THERAPEUTICS
TXN TEXAS INSTRUMENTS INCORPORATED
SMCI SUPER MICRO COMPUTER INC.
RMBS RAMBUS INC.
QCOM QUALCOMM INC
PYPL PAYPAL HOLDINGS INC
PSTG PURE STORAGE INC. CLASS A
PEB PEBBLEBROOK HOTEL TRUST
NVMI NOVA MEASURING INSTRUMENTS LTD
NVDA NVIDIA CORPORATION
MGNX MACROGENICS INC.
FORM FORMFACTOR INC.
FAN FABRINET
FFWM FIRST FOUNDATION
APEI AMERICAN PUBLIC EDUCATION
ALLY ALLY FINANCIAL INC
ACU ACME UNITED CORP.
ELTK ELTEK
BKD BANGKOK DEC-CON
KLAC KLA CORPORATION
PLAB PHOTRONICS INC.
FLXS FLEXSTEEL INDUSTRIES INC.
MRUS MERUS B V
ATGE ADTALEM GLOBAL EDUCATION INC.
AMD ADVANCED MICRO DEVICES INC.
AVGO BROADCOM INC.
DELL DELL TECHNOLOGIES INC CLASS C
BSIG BRIGHTSPHERE INVESTMENT GROUP INC.
ARCH ARCH RESOURCES INC. CLASS A
ORIC ORIC PHARMACEUTICALS
VRT VERTIV HOLDINGS CO (A)
MRVL MARVELL TECHNOLOGY INC
NPCE NEUROPACE INC
EWTX ONTO INNOVATION INC.
IRON EDGEWISE THERAPEUTICS INC
DISC MEDICINE INC
01/22/24 January 22, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch